Ipratropium bromide and Pco2 increased - a phase IV clinical study of FDA data

Summary:

Pco2 increased is reported as a side effect among people who take Ipratropium bromide (ipratropium bromide), especially for people who are female, 20-29 old, also take Theophylline, and have Pulmonary hypertension.

The phase IV clinical study analyzes which people have Pco2 increased when taking Ipratropium bromide. It is created by eHealthMe based on reports of 17,749 people who have side effects when taking Ipratropium bromide from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Pco2 increased?

Pco2 increased is found to be associated with 133 drugs and 358 conditions by eHealthMe. Check the latest studies of Pco2 increased.

On Jul, 16, 2026

17,749 people reported to have side effects when taking Ipratropium bromide.
Among them, 35 people (0.2%) have Pco2 increased.

Could Ipratropium bromide cause Pco2 increased?

Among these 35 people:

What is the gender of people who have Pco2 increased when taking Ipratropium bromide? *

female: 78.79 %
male: 21.21 %

What is the age of people who have Pco2 increased when taking Ipratropium bromide? *

What are other drugs people take besides Ipratropium bromide? *

What are other side effects people have besides Pco2 increased? *

Po2 Decreased: 27 people, 77.14%
Blood Ph Decreased: 25 people, 71.43%
Hypercapnia (too much smoke): 24 people, 68.57%
Oxygen Saturation Decreased: 23 people, 65.71%
Dyspnea (difficult or laboured breathing): 22 people, 62.86%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 22 people, 62.86%
Wheezing (a high-pitched whistling sound made while you breath): 20 people, 57.14%
Lung Hyperinflation (inspiration of more than normal): 19 people, 54.29%
Drug Ineffective: 19 people, 54.29%
Skin Discoloration - Bluish (bluish colour of skin): 18 people, 51.43%

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 8.57%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.86%
Respiratory Distress (difficulty in breathing): 1 person, 2.86%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 1 person, 2.86%
High Blood Pressure: 1 person, 2.86%
Dyspnea (difficult or laboured breathing): 1 person, 2.86%
Chronic Obstructive Airways Disease: 1 person, 2.86%
Cardiac Failure: 1 person, 2.86%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 2.86%
Acute Severe Asthma: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and have Pco2 increased?

- Check whether Pco2 increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ipratropium bromide:

Ipratropium bromide (17,965 reports)

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pco2 increased:

Pco2 increased (133 drugs)

Browse all the conditions that are associated with Pco2 increased:

Pco2 increased (358 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Ipratropium bromide) and Ipratropium bromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.